期刊文献+

氯吡格雷硫酸氢盐晶型Ⅰ与晶型Ⅱ的制备

Preparation of crystalline form Ⅰ and Ⅱ of clopidogrel hydrogen sulfate
下载PDF
导出
摘要 目的探讨氯吡格雷硫酸氢盐晶型Ⅰ与晶型Ⅱ的制备条件。方法采用不同的溶剂、不同的温度等晶型制备方法制备晶型Ⅰ与晶型Ⅱ,并用熔点和X粉末衍射图谱进行鉴别。结果制备了氯吡格雷硫酸氢盐晶型Ⅰ与晶型Ⅱ。结论在晶型Ⅰ与晶型Ⅱ的制备中析晶温度和成盐温度对析晶过程影响较大。 [Abstract] Objective To investigate preparation condition of crystalline form Ⅰ and Ⅱ of clopidogrel hydrogen sulfate. Methods The methods of preparing the polymorphic forms adopted different solvents, temperatures and son on. The determi- nation methods of crystals were melting point and X-ray power diffraction. Results Crystal form Ⅰ and Ⅱ of clopidogel hydrogen sulfate were prepared. Conclusion The crystallization and salification temperature have great effect on crystallization in the preparation of crystal form Ⅰ and Ⅱ.
出处 《福建医药杂志》 CAS 2013年第2期67-69,共3页 Fujian Medical Journal
关键词 氯吡格雷硫酸氢盐 晶型 X-射线粉末衍射 clopidogrel hydrogen sulfate~ crystalline form~ X-ray power diffraction
  • 相关文献

参考文献7

  • 1Badorc A, Frehel D. Dextrorotatory enantiomer of alpha- (4, 5, 6, 7-tetrahydrothieno [3, 2-c] pyrid-5-yl) (2-chlorophe- nyl) methyl acetate, process for its preparation and pharmaceu- tical compositions containing it: EP, 281459 [P]. 1988-09-07.
  • 2Bouisset M, Radison J. Process for the preparation of a-bromo- phenylacetic acids: US, 5036156 [P]. 1991-07-30.
  • 3Revital Lifshitz-Liron, Eti Kovalevski-Ishai. Polymorphs of clo- pidogrel hydrogen sulphate: WO, 03051362 [P]. 2003-06-26.
  • 4Andre bousquet, Bertrand Castro. Polymorph form of clopi- dogrel hydrogen sulphate: US, 6504030 [P]. 2003-06-07.
  • 5Salunke Sanjukumar, Paul Aniruddha. Process for the prepara- tion of clopidogrel bisulphate form I: WO, 200980469 [P]: 2009-07-02.
  • 6潘仙华,毛海舫,郎希红.Ⅰ型氯吡格雷硫酸氢盐的合成及晶型转换[J].精细化工,2006,23(12):1221-1226. 被引量:15
  • 7赵胜贤,夏炯,赵立强,等.高纯度Ⅱ型(4-)-(S)-氯吡格雷硫酸氢盐的制备方法:中国,101643476[P].2011-06-29.

二级参考文献15

  • 1Bouisset M,Radison J.Process for the preparation of α-bromophenylacetic acids[P].US:5 036 156,1991-07-30.
  • 2Badorc A,Frehel D.Dextrorotatory enantiomer of alpha-(4,5,6,7-tetrahydrothien o[3,2-c] pyrid-5-yl) (2-chlorophenyl) methyl acetate,process for its preparation and pharmaceutical compositions containing it[P].EP:281 459,1988 -09 -07.
  • 3Eliel E L,Fisk M T,Prosser T.Org.Synth[M].John Wiley &Sons:Coll.vol.Ⅳ,1963.169-172.
  • 4Schror K.The basic pharmacology of ticlopidine and clopidogrel[J].Platelets,1993,4(2):252 -261.
  • 5Herbent J M,Frehel D,Vallee K.Clopidogrel,a novel antiplatelet and antithrombotic agent[J].CardIotuscular Drug RevIews,1993,11(2):180-198.
  • 6Andre B S,Bertrand C K,Jean S G.Polymorphic clopidogrel hydrogenesulphate form[P].US:6 429 210,2002-08-06.
  • 7OfficIal Gazette of the United States Patent & Trademark Office Patents[M].USA:2003.1,1266.
  • 8Srinivas R M.Venkateswar,R P Amorphous clopidogrel hydrogen sulfate composition field of the invention[P].WO:2 004 098 593,2004-11-18.
  • 9Jean E F R,Wylie W V J.GRF analogs[P].US:4 529 595,1985-06-16.
  • 10Helmut K W.Impact mechanism for impact printer[P].US:4874 265,1985-10-17.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部